PDEI + 5‐ARI vs 5‐ARI alone
Adverse events
The review found no eligible studies for this question.
2 findings from 1 review
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyRR 1.07 [0.84, 1.36]1 study · 695 participantsLow